Researchers say CSF biomarker test correlates with the severity of cognitive decline, independent of other factors, including brain amyloid deposition.
Hosted on MSN5mon
Promising immunotherapy treatment targets multiple pathogenic hallmarks of Alzheimer's diseaseThe immunotherapy, which Lovell and his team developed, includes epitopes from both Aβ and tau proteins. These are mixed with special liposomes, or tiny fat bubbles, which help deliver the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback